Neutropenia
📧 Sign up to get email alerts when something new happens for Neutropenia.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2025-06-04EMA Application withdrawn: Pelgraz Paediatric (pegfilgrastim) — Accord Healthcare S.L.U.
The EMA has withdrawn the application for Pelgraz Paediatric (pegfilgrastim) submitted by Accord Healthcare S.L.U., in the therapeutic areas…
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant [NA]
This clinical trial update indicates that the study evaluating a donor stem cell boost for patients with low blood cell counts after a donor…
-
CLINICAL_TRIALS withdrawal · 2024-12-30Clinical Trial Update: Remote Monitoring of Patients at Risk of Sepsis [NA]
A trial investigating remote monitoring of patients at risk of sepsis, including those with neutropenia and cancer, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-04-27Clinical Trial Update: Fever and Neutropenia in Pediatric Oncology Patients [Phase 3]
A Phase 3 pediatric oncology trial investigating fever and neutropenia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-05Clinical Trial Update: A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of recombinant human mannose-binding lectin (rhMBL) in pediatric oncolog…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-06-20Clinical Trial Update: Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia [Phase 1]
A Phase 1 trial of recombinant human Mannose-Binding Lectin (MBL) in young patients with MBL deficiency and fever with neutropenia was withd…